LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

Search

Medpace Holdings Inc

Închisă

SectorSănătate

582.97 -1.08

Rezumat

Modificarea prețului

24h

Curent

Minim

581.83

Maxim

592.9

Indicatori cheie

By Trading Economics

Venit

21M

111M

Vânzări

57M

660M

P/E

Medie Sector

42.018

105.69

Marjă de profit

16.841

Angajați

6,200

EBITDA

32M

150M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

-11.05% downside

Statistici piață

By TradingEconomics

Capitalizare de piață

1.6B

17B

Deschiderea anterioară

584.05

Închiderea anterioară

582.97

Sentimentul știrilor

By Acuity

50%

50%

185 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Medpace Holdings Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 oct. 2025, 15:15 UTC

Câștiguri

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Comparație

Modificare preț

Medpace Holdings Inc Așteptări

Obiectiv de preț

By TipRanks

-11.05% jos

Prognoză pe 12 luni

Medie 524.89 USD  -11.05%

Maxim 655 USD

Minim 425 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMedpace Holdings Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

10 ratings

1

Cumpărare

7

Păstrare

2

Vânzare

Scor tehnic

By Trading Central

300 / 302.88Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

185 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat